![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/AbdullahMUFTIC.jpg\")
<\/p>\n<\/p>\n
A. Mufti\u0107<\/strong>*, Z. Imamovi\u0107<\/strong>, M. Bisi\u0107<\/strong>, J. \u0160upi\u0107<\/strong>, A. Ali\u0107<\/strong> and E. Mufti\u0107<\/strong><\/p>\n <\/a><\/p>\n <\/a> ▲<\/a><\/p>\n The objective of this paper was to create an economical and abecedarian 3D printing method for the production of solid microneedles, as a more efficient transdermal drug delivery method, for day-to-day use in companion animals. The process of 3D printing was conducted using two types of 3D printers, utilizing the FDM and SLA printing techniques. Modulus of Elasticity was calculated for the determination of mechanical properties of the material, where the printed specimen was subjected to axial loading, and deformations were measured using an optical scanner. Post-processing was conducted by washing microneedles in isopropyl alcohol, followed by UV curing. The procedure of testing penetration capabilities was conducted at two sites of cat skin: auris externa<\/em> and the lateral part of the abdomen. The SLA printing method was more precise, resulting in higher quality microneedles for animal use compared to the FDM printing technique. Modulus of Elasticity was calculated and the value E=0.9 Gpa can be used. Testing proved that the printed model was able to penetrate the skin at the tested sites. The use of microneedles is simple and economical, and therefore has wide applications in small animal practice. Veterinarians can access microneedle design repositories and print them for more effective transdermal drug delivery. The multifunctionality and transferability of the design in the present study ensure that it can be further modified to provide personalized therapy.<\/p>\n Key words:<\/strong> 3D printing; microneedle; transdermal drug delivery; companion animals<\/em><\/p><\/blockquote>\n <\/a> ▲<\/a><\/p>\n Avoidance of emotional stress and needle-caused injuries associated with the usual treatment of animals, while improving animal compliance during veterinary procedures should be one of the main goals of animal welfare. These objectives could be fulfilled by achieving easier methods of medication administration, such as cutaneous delivery. Several methods for transdermal drug delivery have been developed, though most have had limited success due to the problems regarding the transfer of high molecular weight compounds across the skin (Langer, 2004). Microneedles (Mns) are novel, microscopic-size applicators used for medical treatments. Several studies have emphasized the advantages of using Mns, as they are a less painful and more efficient way of transdermal drug delivery (Teo et al<\/em>., 2006; Indermun et al<\/em>., 2014). Nowadays, Mns are mainly produced using 3D printing techniques (Dabbagh et al<\/em>., 2021). A microneedle array (MNA) is composed of single or multiple individual Mns on a flat base (substrate). The selection of the 3D printing technique is based on several factors, including the size and design of Mns, printing material (resin and filaments), and the required finish quality of the product (Dabbagh et al<\/em>., 2021). While Composite Extrusion Modelling (CEM) and Filament Metal Printing (FMP) are 3D printing techniques for the production of multiuse MNAs, Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), and Stereolithography (SLA) are mainly used for the production of expendable MNAs (Economidou and Douroumis, 2021). SLA 3D printers belong to a family of additive manufacturing technologies known as vat-photopolymerization, commonly known as resin 3D printing. These machines are all built around the same principle, using a light source \u2013 a laser or projector \u2013 to cure liquid resin into hardened plastic. SLA 3D printers use light-reactive thermoset materials (resin). When SLA resins are exposed to certain wavelengths of light, short molecular chains join together, polymerizing monomers and oligomers into solidified rigid or flexible geometries (Ma, 2013). A possible drawback regarding the production of Mns and MNAs is the high cost, mainly due to significant power consumption by 3D printers, and the price of printing materials. In addition, the selection of 3D printing material is another issue since the selected material has to comply with basic principles of structural integrity when inserted into the animal skin.<\/p>\n There are insufficient data about mechanical properties such as the Modulus of Elasticity, which is essential regarding the safety of using devices made from this material in veterinary medicine. There are several options regarding the design and structure of Mns, including solid, hollow, and intradermal-soluble designs that are suitable for different purposes. Solid Mns are the most versatile of the aforementioned since they allow the implementation of the poke-and-patch method, either with or without drug coating (Quinn et al<\/em>., 2014). The poke-and-patch method consists of the use of Mns to penetrate the stratum corneum<\/em> while creating micropores. This method substantially improves topical drug delivery since the main defensive barrier of the skin is disrupted (Gupta et al<\/em>., 2011).<\/p>\n This study aimed to create an economical and abecedarian 3D printing method for the production of solid MNAs using inexpensive and harmless printing materials and SLA printing techniques for dayto-day use in transdermal drug delivery in companion animals. This study also aimed to determine the Modulus of Elasticity of the selected material to act by the \u201cDo no harm\u201d principle of veterinary medicine.<\/p>\n <\/a> ▲<\/a><\/p>\n The methods applied in the present study are divided into three subcategories due to the specificity of each process.<\/p>\n Two types of 3D printers were used based on the FDM and SLA printing techniques. FDM 3D printers work by extruding thermoplastic filaments through a heated nozzle, melting the material, and applying the plastic layer by layer to a build platform. For the test, Ultimaker S5 Pro (Ultimaker\u00ae<\/sup>, The Netherlands) with a 0.4 mm nozzle was used with PLA filament and maximum quality profile. The SLA 3D printer used in this project was Anycubic Photon Mono X (Anycubic\u00ae<\/sup>, China).<\/p>\n Computer-aided design (CAD) of MNs has a height of 2 mm, and 0.5 mm since plastic shrinkage was expected. In the present study, the slicer Chitubox V1.9.0 (CBD-Tech\u00ae<\/sup>, China) was used. The model of MNs was designed to have 12 rows of 12 needles per row (144 MNs) placed on a 200 mm plate that serves as a substrate (Figure 1). <\/p>\n A fully designed model from CAD software was saved as an .stl extension and was accessed by the software used for preparing CAD files for 3D printing (slicer).<\/p>\n The parameters set for the 3D printing of MNs were: Post-processing was conducted by washing MNAs in isopropyl alcohol for 20 minutes, followed by UV curing for 20 minutes.<\/p>\n The finished design product in both .stl and .pwmx extensions is available in the GitHub repository (GitHub, 2021).<\/p>\n The material used for 3D printing was Anycubic UV 405 nm 3D Resin (Anycubic\u00ae<\/sup>, China). Due to the need to obtain the Modulus of Elasticity for the used material, the experimental method was used, where the printed specimen was subjected to axial loading, and deformations were measured via an optical scanner ATOS Core (Atos\u00ae, France). ATOS Core<\/em> specializes in 3D scanning of small and medium objects up to 200 x 150 x 150 mm. This device, in addition to 3D scanning of body shapes of correct and incorrect geometry, allows the measurement of deformations, displacements, displacement speeds, etc. After scanning, the file was opened in a compatible Generic Object Model (GOM) software solution in which it was possible to analyse the deformations of the recorded object.<\/p>\n After 3D printing, the specimen had the following initial dimensions: The cross-sectional area of the specimen was:<\/p>\n For the optical scanner to recognize points on the loaded specimen, the scanning area needed to be prepared \u2013 painted in white, with many black points (Figure 2).<\/p>\n Such contrast was sufficient for the scanner to discern points and measure their relative deformations (Kljuno et al<\/em>., 2021a; Yadav et al<\/em>., 2021).<\/p>\n During the experiment, a clamp was used together with an electric sensor where the battery input voltage (U) was 12.8 V and the response was defined by the constant k<\/em>:<\/p>\n Each phase was recorded with the ATOS Core<\/strong> scanner during the loading process. After scanning, files were processed in GOM Correlate Inspect (Carl Zeiss AG\u00ae<\/sup>, Germany) numerical software and relative deformation in the x-axis \u03b5x<\/sub>exp<\/sup> was observed.<\/p>\n Determination of the Modulus of Elasticity was conducted by calculating several physical measures. The compressive force of the clamp depends on the encoder output voltage and was determined from the next relation:<\/p>\n where Uo<\/sub> [mV] is an output voltage through the phase (i = 1,2,3\u2026) of amplifying axial loading.<\/p>\n At phase i = 7 output voltage measured U7<\/sub> = 2.04 mV, therefore compressive force at this phase was:<\/p>\n At this phase, the absolute deformation of the specimen (\u2206L<\/em>) was calculated by taking the difference between measured lengths of the clamp at phases i = 7 and i = 2. At phase i = 2 clearance between the specimen and clamp jaws was zero. Knowing the absolute deformation and initial length of the specimen, relative deformation in the axial (x) axis was analytically determined as:<\/p>\n Using the results from the software, we can obtain a value of relative deformation for phase , the same phase where analytical approaches were used. Due to the dispersion of the results of relative deformation at different points, a set of a large number of points (n<\/em>=17) was taken into consideration (Figure 3).<\/p>\n Using the simple average value method, the experimental relative deformation of the polymer specimen in the load phase i = 7 was:<\/p>\n By obtaining the relative deformation of the polymer specimen, it was possible to determine the Modulus of Elasticity (Goodier and Timoshenko, 1970; Rees, 2016).<\/p>\n The skin of a cat that recently perished from collision with a vehicle was used as the biological model for MN testing. Testing was conducted at the Laboratory for Pathology. The procedure of testing MN penetration capabilities was conducted at two sites: the auris externa<\/em>, selected since the skin is thinnest on this part of the animal body, and the lateral part of the abdomen where adipose tissue is mainly located (Noli and Colombo, 2020). At both of testing sites, the skin was intact.<\/p>\n Simple visualization was conducted to observe whether MNs successfully penetrated the skin. Subsequently, puncture sites were observed by the Z4 Zoom Stereoscope (LW Scientific\u00ae<\/sup>, USA).<\/p>\n For the poke-and-patch test, the procedure of MN application was conducted by pressing the device onto the skin with the thumb and removing it after 5 seconds. <\/a> ▲<\/a><\/p>\n The FDM printing method provided inadequate quality of MNs which had unsatisfactory shape and form, and did not achieve the desired precision for animal use. The SLA printing method was more precise, resulting in MNs of higher quality for animal use (Figure 1). Furthermore, the number of MNAs varied greatly between the two tested methods for a similar printing time. The duration of the SLA printing method was 15 minutes, which was 3 minutes slower compared to FDM printing. However, when using SLA 3d printers, 50 MNAs were printed simultaneously in 15 minutes, compared to using FDM printers where the total printing time was 600 minutes (12 minutes for each of the 50 MNAs individually).<\/p>\n The measured mean size (x\u0304) of MNs post-printing was 481 \u00b5m (441\u2013512 \u00b5m), with MNs longer at the border of the substrate (x\u0304 = 497 \u00b5m) than in the centre (x\u0304 = 463 \u00b5m). Exposure to UV light triggers the formation of additional chemical bonds within the 3D-printed part, making the material stronger and stiffer in the process. Furthermore, the curing process transforms MNs into non-toxic and safe objects, which is a requirement when using MNs on animal skin.<\/p>\n Using Hooks Law \u03c3 = E\u2219\u03b5x<\/sub> and relation for the normal stress in the axially loaded bar \u03c3 = F\/A, with the analytically obtained value of relative deformation \u03b5x<\/sub>ana<\/sup>, the Modulus of Elasticity in the printed specimen was calculated:<\/p>\n Using the Hook\u2019s relation and equal stress exposure in the analytical approach, the Modulus of Elasticity of the resin, with the experimentally obtained Value of Relative Deformation \u03b5x<\/sub>exp<\/sup> using a 3D scanner was determined:<\/p>\n The approximate value between these two for the given material of MNs, can be used.<\/p>\n Testing of MNs showed that the printed model was able to penetrate the skin at the auris externa<\/em> (Figure 4), and on the lateral part of the abdomen.<\/p>\n It is concluded that the pressure required for puncturing is not greater than the pressure exercised by a thumb.<\/p>\n Differences between application sites were not observed. Changes between punctures in the skin were not observed whether MNs were removed instantly post-application, or left inserted for 10 minutes.<\/p>\n <\/a> ▲<\/a><\/p>\n The literature highlighting the importance of 3D printed Mns has grown rapidly in recent years for human medicine (Dabbagh et al<\/em>., 2021). The advantage of Mns is that they are well tolerated and less painful than traditional hypodermic needles (Banks et al<\/em>., 2011). The utilization of the poke-and-patch method of Mns application is the most common one. Its simplicity, from a technical viewpoint, makes it attractive for clinical use (Guillot et al<\/em>., 2020). A study conducted in 2011 on Mns pre-treatment followed by application of a transdermal naltrexone patch led to higher naltrexone plasma levels in healthy human subjects compared to traditional patch application (Banks et al<\/em>., 2011). These findings are not the exception since the majority of research has accentuated the improvement in the bioavailability of vitamins (Kim et al<\/em>., 2018), hormones (Resnik et al<\/em>., 2018), antibiotics (Risbud and Bhonde, 2000), therapeutic proteins (Cheung et al<\/em>., 2015), and natural compounds (Paleco et al<\/em>., 2014) during the poke-and-patch method in human medicine. Furthermore, since topical medication is widely used in both human (Bewley, 2008; Mooney et al<\/em>., 2015) and veterinary medicine (Breen and Johnson, 1977), MNAs should reduce dosage while providing a similar or better effect in animal healthcare.<\/p>\n Since animal skin has a substantially thinner epidermis (Schwarz et al<\/em>., 1979; Noli and Colombo, 2020) and the nociceptors are closer to the skin surface, the Mns designed for human use could prove inadequate due to the possible pain of application of Mns inflicted on the animal. Unfortunately, Mns and MNAs have not had the same popularity in veterinary medicine, with only several papers published regarding their uses. Knowing the value of the Modulus of Elasticity allows numerical analysis of the load, i.e.<\/em>, strength, and stability of Mns made from biocompatible materials that would be applied as a final product. With the virtue of this research, future changes could be made by taking these findings into account. Further research on the use of solid Mns would include an accurate assessment of animal skin penetration using histological methods and animal models. The multifunctionality and transferability of the design in the present study ensure that it can be further modified to provide personalised therapy. If the need arises in the production of hollow or coated Mns, this design will prove useful as a starting point for future alterations.<\/p>\n <\/a> 1.\tARYA, J. M., K. DEWITT, M. SCOTT-GARRARD, Y. W. CHIANG and M. R., PRAUSNITZ (2016): Rabies vaccination in dogs using a dissolving microneedle patch. J. Control. Release 239, 19-26. 10.1016\/j.jconrel.2016.08.012 <\/a> ▲<\/a><\/p>\n Cilj ovog rada je kreiranje ekonomi\u010dne i abecedarne metode 3D printanja za proizvodnju \u010dvrstih mikroigli, kao u\u010dinkovitije transdermalne metode aplikacije lijeka, za svakodnevnu uporabu u ku\u0107nih ljubimaca. Proces 3D printanja se provodi pomo\u0107u nekoliko tipova 3D printera, koriste\u0107i FDM i SLA tehnike printanja. Modul elasticiteta izra\u010dunat je za odre\u0111ivanje mehani\u010dkih svojstava kori\u0161tenog materijala, pri \u010demu je printani uzorak podvrgnut aksijalnom optere\u0107enju, a deformacije su mjerene opti\u010dkim skenerom. Naknadna obrada je obavljena ispiranjem MNA u izopropil alkoholu, nakon \u010dega je uslijedilo UV su\u0161enje. Procedura ispitivanja sposobnosti penetracije Mns provedena je na dva mjesta na ko\u017ei ma\u010dke: auris externa<\/em> i lateralni dio abdomena. SLA metoda printanja bila je preciznija, \u0161to je rezultiralo mikroiglama ve\u0107e kvalite za uporabu na \u017eivotinjama u usporedbi s FDM tehnikom printanja. Modul elasticiteta je izra\u010dunat i mo\u017ee se koristiti vrijednost E=0,9 Gpa. Testiranje printanih mikroigli je pokazalo da je model bio u stanju da penetrira u ko\u017eu na testiranim podru\u010djima. Uporaba mikroigli je jednostavna i ekonomi\u010dna, stoga mo\u017ee biti \u0161iroko rasprostranjena u praksi malih \u017eivotinja. Veterinari mogu pristupiti repozitorijumima dizajna mikroigli i sami iste printati, kako bi ih koristili za u\u010dinkovitiju transdermalnu aplikaciju lijekova. Multifunkcionalnost i primjenjivost dizajna u ovoj studiji osiguravaju mogu\u0107nost daljnje modifikacije da bi se omogu\u0107ila indivudualna terapija.<\/p>\n Klju\u010dne rije\u010di:<\/strong> 3D printanje, mikroigle, transdermalna isporuka lijekova, ku\u0107ni ljubimci<\/em><\/p><\/blockquote>\n","protected":false},"excerpt":{"rendered":" A. Mufti\u0107*, Z. Imamovi\u0107, M. Bisi\u0107, J. \u0160upi\u0107, A. Ali\u0107 and E. Mufti\u0107 Abdullah MUFTI\u0106, DVM, Senior Assistant, (Corresponding author,<\/p>\n","protected":false},"author":8,"featured_media":0,"menu_order":3,"comment_status":"closed","ping_status":"open","template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[1941,1944,1942,1943],"issuem_issue":[1880],"ppma_author":[1638,1937,1938,1939,1940,1636],"class_list":["post-6548","article","type-article","status-publish","format-standard","hentry","category-original-scientific-articles","tag-3d-printing","tag-companion-animals","tag-microneedle","tag-transdermal-drug-delivery","issuem_issue-veterinarska-stanica-55-1"],"yoast_head":"\n
\nAbdullah MUFTI\u0106<\/strong>, DVM, Senior Assistant, (Corresponding author, e-mail: abdullah.muftic@vfs.unsa.ba), University of Sarajevo \u2013 Veterinary Faculty, Sarajevo, Bosnia and Herzegovina; Zejd IMAMOVI\u0106<\/strong>, MSc Mechanical Engineering, Senior Assistant, University of Sarajevo \u2013 Faculty of Mechanical Engineering, Sarajevo, Bosnia and Herzegovina; Muhamed BISI\u0106<\/strong>, BSc, Mechanical Engineering, Student, University of Sarajevo \u2013 Faculty of Mechanical Engineering, Sarajevo, Bosnia and Herzegovina; Jovana \u0160UPI\u0106<\/strong>, DVM, Senior Assistant, University of Sarajevo \u2013 Veterinary Faculty, Sarajevo, Bosnia and Herzegovina; Amer ALI\u0106<\/strong>, DVM, PhD, Associate Professor, University of Sarajevo \u2013 Faculty of Veterinary Faculty, Sarajevo, Bosnia and Herzegovina; Emina MUFTI\u0106<\/strong>, DVM, Senior Assistant, University of Sarajevo \u2013 Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina<\/div>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2021\/03\/pdf.png\")
<\/a>https:\/\/doi.org\/10.46419\/vs.55.1.6<\/a><\/div>\n<\/p>\n\nAbstract<\/a>Introduction<\/a>Materials and methods<\/a>Results<\/a>Discussion<\/a>References<\/a>Sa\u017eetak<\/a><\/span><\/div>\n<\/div>\n\n
Abstract<\/h2>\n
\nIntroduction<\/h2>\n
\n
\nMns facilitate drug diffusion by piercing microscale pores in the stratum corneum<\/em>, while not affecting nociceptors in the skin, thus eliminating or minimizing pain. Additionally, Mns reduce the required doses and improve the bioavailability of used medicines by avoiding the degradation of drugs in the gastrointestinal tract, which reduces plasma level oscillations often caused by other types of treatments (Teo et al<\/em>., 2004; Papich and Narayan, 2022).
\nMost studies on Mns to date have focused on human use of the product and are executed regarding the composition and thickness of human skin. Animal skin, predominantly the epidermis<\/em>, is substantially thinner (Schwarz et al<\/em>., 1979; Noli and Colombo, 2020), thus making human-focused Mns inconvenient for use in animals. However, MN manufacturing is not an easy process, since it demands the usage of specialized equipment capable of producing needles of microscopic scale.<\/p>\n
\nModulus of Elasticity is the measurement of a material\u2019s resistance to deformation when stress is applied (Askeland, 1996).
\nThe Modulus of Elasticity of polymer pieces obtained by 3D printing depends on the material and printing techniques (layer thickness, printing precision, etc.).<\/p>\nMaterials and methods<\/h2>\n
\nProcess of 3D printing<\/h3>\n
![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/figure01-development-of-solid.jpg\")
\n\u2022 Layer height: 0.025 mm
\n\u2022 Bottom layer count: 4
\n\u2022 Exposure Time: 1.1 s
\n\u2022 Bottom Exposure Time: 40 s
\n\u2022 Lifting speed: 180 mm\/min
\n\u2022 Retract speed: 240 mm\/min<\/p>\nDetermination of mechanical properties<\/h3>\n
\nL0<\/sub> = 83 mm \u2012 length
\nt = 20.5 mm \u2012 thickness
\nb = 50.2 mm \u2012 width<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-01.png\")
<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/figure02-development-of-solid.jpg\")
![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-02.png\")
<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-03.png\")
<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-04.png\")
<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-05.png\")
<\/p>\n
\nAlso, local kneading of the moving jaw of a clamp into the polymer needed to be considered to obtain the correct result.
\nAfter inspecting, this local kneading was approximately (\u03b4lk<\/sub>). Finally, absolute deformation was:<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-06.png\")
<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-07.png\")
<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/figure03-development-of-solid.jpg\")
![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-08.png\")
<\/p>\nTesting of MNAs<\/h3>\n
\nMNs applied to the auris externa<\/em> were removed instantly post-application, and MNs on the lateral part of the abdomen were left inserted for 5 minutes to observe differences in application methods.<\/p>\nResults<\/h2>\n
\nPrinting process, analytical and experimental determination of the Modulus of Elasticity of MNA material<\/h3>\n
![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-09.png\")
<\/p>\n![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/development-of-solid-10.png\")
<\/p>\nTesting of MNAs<\/h3>\n
![\"\"](\"https:\/\/veterinarska-stanica-journal.hr\/wp-content\/uploads\/2023\/06\/figure04-development-of-solid.jpg\")
Discussion<\/h2>\n
\n
\nTo the best of our knowledge, there are no studies regarding the design of solid Mns and MNAs for use in companion animals. Research within the scope of veterinary medicine have not provided a design for the most versatile type of Mns \u2013 solid Mns but have instead been focused on the effects of dissolvable (Arya et al<\/em>., 2016) and insertion-responsive (Choi et al<\/em>., 2020) Mns in immunoprophylaxis of animals. Based on our research, the SLA printing technique is a better choice for solid MNAs for animal use since the sizes are microscopic and precision is often problematic. The SLA printing technique provided better precision and quality of the finished product compared to FDM. To create an adequate design of solid Mns, certain physical properties of the used material had to be met. The Modulus of elasticity and relative deformation are the most important mechanical properties of a material (Goodier and Timoshenko, 1970). For 3D printed Mns and MNAs, these physical properties can be determined either by experiment \u2013 using an optical scanner, or by using the analytical approach (Kljuno et al<\/em>., 2021b). The similarity of results obtained by analytical and experimental methods allows employing either of them in material testing for future Mns designs and different Mns application procedures. Due to the simplicity of the experimental method, and the similarity of results comparing the two methods, avoiding the analytical method and testing only via an optical scanner should prove adequate.<\/p>\n
\nRegardless, it would be necessary to determine the toughness of animal skin to create Mns of reciprocal characteristics for safe application without substantial deformation occurrence. To the best of our knowledge, fundamental studies determining the physical properties of animal skin are yet to be conducted.<\/p>\n
\nReferences<\/strong> [… show]<\/span><\/a><\/span><\/p>\n ▲<\/a><\/p>\n
\n2.\tASKELAND, D. R. (1996): Introduction to materials. In: Askeland, D. R., P. P. Fulay and W. J. Wright: The science and engineering of materials. Springer (2-17).
\n3.\tBANKS, S. L., K. S. PAUDEL, N. K. BROGDEN, C. D. LOFTIN and A. L. STINCHCOMB (2011): Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin. Pharm. Res. 28, 1211-1219. 10.1007\/s11095-011-0372-2
\n4.\tBEWLEY, A. (2008): Dermatology Working Group. Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br. J. Dermatol. Suppl. 158, 917-920. 10.1111\/j.1365-2133.2008.08479.x
\n5.\tGitHub (2021): 3D STL Design of microneedles with sliced .pwmx file for SLA 3D printing https:\/\/github.com\/bisk3\/Mns?fbclid=IwAR13tHCVZNH- -3Tzxo0kzBJspPkpXQ6QcuVvuPHbRNQBFtXxW bN-yYMhgsU [Accessed March 21st, 2023].
\n6.\tBREEN, P. T. and G. L. JOHNSON (1977): Epidermal atrophy [in a dog] caused by excessive use of a topical corticosteroid: a case report. J. Am. Anim. Hosp. Assoc. 13, 713-715.
\n7.\tCHEUNG, K., G. WEST and D. B. DAS (2015): Delivery of large molecular protein using flat and short microneedles prepared using a focused ion beam (FIB) as a skin ablation tool. Drug Deliv. Transl. Res. 5, 462-467. 10.1007\/s13346-015-0252-0
\n8.\tCHOI, I. J., W. NA, A. KANG, M. H. AHN, M. YEOM, H. O. KIM, J. W. LIM, S. O. CHOI, S. K. BAEK, D. SONG and J. H. PARK (2020): Patchless administration of canine influenza vaccine on dog\u2019s ear using insertion-responsive microneedles (IRMN) without removal of hair and its in vivo efficacy evaluation. Eur. J. Pharm. Biopharm. 153, 150-157. 10.1016\/j.ejpb.2020.06.006
\n9.\tDABBAGH, S. R., M. R. SARABI, R. RAHBARGHAZI, E. SOKULLU, A. K. YETISEN and S. TASOGLU (2021): 3d-printed microneedles in biomedical applications. iScience 24, 102012. 10.1016\/j.isci.2020.102012
\n10.\tECONOMIDOU, S. N. and D. DOUROUMIS (2021): 3d printing as a transformative tool for microneedle systems: Recent advances, manufacturing considerations and market potential. Adv. Drug Deliv. Rev. 173, 60-69. 10.1016\/j.addr.2021.03.007
\n11.\tGOODIER, J. N. and S. TIMOSHENKO (1970): Theory of elasticity. McGraw-Hill.
\n12.\tGUILLOT, A. J., A. S. CORDEIRO, R. F. DONNELLY, M. C. MONTESINOS, T. M. GARRIGUES and A. MELERO (2020): Microneedle-based delivery: an overview of current applications and trends. Pharmaceutics 12, 569. 10.3390\/pharmaceutics12060569
\n13.\tGUPTA, J., H. S. GILL, S. N. ANDREWS and M. R. PRAUSNITZ (2011): Kinetics of skin resealing after insertion of microneedles in human subjects. J. Control. Release. 154, 148-155. 10.1016\/j.jconrel.2011.05.021
\n14.\tINDERMUN, S., R. LUTTGE, Y. E. CHOONARA, P. KUMAR, L. C. DU TOIT, G. MODI and V. PILLAY (2014): Current advances in the fabrication of microneedles for transdermal delivery. J. Control. Release. 185, 130-138. 10.1016\/j.jconrel.2014.04.052
\n15.\tKIM, H. G., D. L. GATER and Y. C. KIM (2018): Development of transdermal vitamin D3 (VD3) delivery system using combinations of PLGA nanoparticles and microneedles. Drug Deliv. Transl. Res. 8, 281-290. 10.1007\/s13346-017-0460-x
\n16.\tKLJUNO, E., F. RAZIC, A. CATOVIC and E. MESIC (2021): Deformation and stress analysis of a U-shaped pipe compensator using a 3d scanner. Period. Eng. Nat. Sci. 9, 830-841. 10.21533\/pen.v9i2.1900
\n17.\tKLJUNO, E., F. RAZIC, E. MESIC and A. CATOVIC (2021): Structural stress and strain analysis using a 3d scanner. International Symposium on Innovative and Interdisciplinary Applications of Advanced Technologies. Springer, Cham (617-634).
\n18.\tLANGER, R. (2004): Transdermal drug delivery: past progress, current status, and future prospects. Adv. Drug Deliv. Rev. 56, 557-558. 10.1016\/j.addr.2003.10.021
\n19.\tMA, X. L. (2013): Research on application of SLA technology in the 3d printing technology. Appl. Mech. Mater. 401, 938-941.
\n20.\tMOONEY, E., M. RADEMAKER, R. DAILEY, B. S. DANIEL, C. DRUMMOND, G. FISCHER, R. FOSTER, C. GRILLS, A. HALBERT, S. HILL and E. KING (2015): Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement. Australas. J. Dermatol. 56, 241-251. 10.1111\/ajd.12313
\n21.\tNOLI, C. and S. COLOMBO (2020): Feline Dermatology. Springer Nature.
\n22.\tPALECO, R., S. R. VUCEN and A. M. CREAN (2014): Enhancement of the in vitro penetration of quercetin through pig skin by combined microneedles and lipid microparticles. Int. J. Pharm. 472, 206-213. 10.1016\/j.ijpharm.2014.06.010
\n23.\tPAPICH, M. G. and R. J. NARAYAN (2022): Naloxone and nalmefene absorption delivered by hollow microneedles compared to intramuscular injection. Drug Deliv. Transl. Res. 12, 376-383. 10.1007\/s13346-021-01096-0
\n24.\tQUINN, H. L., M. C. KEARNEY, A. J. COURTENAY, M. T. MCCRUDDEN and R. F. DONNELLY (2014): The role of microneedles for drug and vaccine delivery. Expert Opin. Drug. Deliv. 11, 1769-1780. 10.1517\/17425247.2014.938635
\n25.\tREES, D. W. (2016): Mechanics of solids and structures. World Scientific Publishing Company.
\n26.\tRESNIK, D., M. MO\u017dEK, B. PE\u010cAR, A. JANE\u017d, V. URBAN\u010cI\u010c, C. ILIESCU and D. VRTA\u010cNIK (2018): In vivo experimental study of noninvasive insulin microinjection through hollow Si microneedle array. Micromachines 9, 40. 10.3390\/mi9010040
\n27.\tRISBUD, M. V. and R. R. BHONDE (2000): Polyacrylamide-chitosan hydrogels: in vitro biocompatibility and sustained antibiotic release studies. Drug Deliv. 7, 69-75. 10.1080\/107175400266623
\n28.\tSCHWARZ, R., J. M. W. LE ROUX, R. SCHALLER and K. NEURAND (1979): Micromorphology of the skin (epidermis, dermis, subcutis) of the dog. Onderstepoort J. Vet. Res. 46, 105-109. hdl.handle.net\/2263\/53794
\n29.\tTEO, A. L., C. SHEARWOOD, K. C. NG, J. LU and S. MOOCHHALA (2006): Transdermal microneedles for drug delivery applications. Mater. Sci. Eng. B Solid State Mater. Adv. Technol. 132, 151-154. 10.1016\/j.mseb.2006.02.008
\n30.\tYADAV, P. R., M. N. MUNNI, L. CAMPBELL, G. MOSTOFA, L. DOBSON, M. SHITTU, S. K. PATTANAYEK, M. J. UDDIN and D. B. DAS (2021): Translation of polymeric microneedles for treatment of human diseases: Recent trends, Progress, and Challenges. Pharmaceutics 13, 1132.10.3390\/pharmaceutics13081132
\n<\/em><\/p>\n<\/div>\n\n
Razvoj \u010dvrstih mikroigala za transdermalnu aplikaciju lijekova u ku\u0107nih ljubimaca<\/h2>\n
\nAbdullah MUFTI\u0106<\/strong>, dr. med. vet., vi\u0161i asistent, Univerzitet u Sarajevu \u2013 Veterinarski fakultet, Sarajevo, Bosna i Hercegovina; Zejd IMAMOVI\u0106<\/strong>, MSc ma\u0161instva, vi\u0161i asistent, Univerzitet u Sarajevu \u2013 Ma\u0161inski fakultet, Sarajevo, Bosna i Hercegovina; Muhamed BISI\u0106<\/strong>, BSc ma\u0161instva, student, Univerzitet u Sarajevu \u2013 Ma\u0161inski fakultet, Sarajevo, Bosna i Hercegovina; Jovana \u0160UPI\u0106<\/strong>, dr. med. vet., vi\u0161i asistent, Univerzitet u Sarajevu \u2013 Veterinarski fakultet, Sarajevo, Bosna i Hercegovina; dr. sc. Amer ALI\u0106<\/strong>, dr. med. vet., izvanredni profesor, Univerzitet u Sarajevu \u2013 Veterinarski fakultet, Sarajevo, Bosna i Hercegovina; Emina MUFTI\u0106<\/strong>, dr. med. vet., vi\u0161i asistent, Univerzitet u Sarajevu \u2013 Farmaceutski fakultet, Sarajevo, Bosna i Hercegovina<\/div>\n
\n